UBS Group AG - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$342,000
-93.5%
85,575
-92.1%
0.00%
-100.0%
Q3 2019$5,294,000
+34.6%
1,080,367
+67.3%
0.00%0.0%
Q2 2019$3,932,000
+15023.1%
645,669
+14087.4%
0.00%
Q1 2019$26,000
-45.8%
4,551
+27.6%
0.00%
Q4 2018$48,000
+29.7%
3,566
+85.3%
0.00%
Q3 2018$37,000
-36.2%
1,924
-15.2%
0.00%
Q2 2018$58,000
-66.1%
2,269
-73.3%
0.00%
Q1 2018$171,000
+185.0%
8,491
+186.4%
0.00%
Q4 2017$60,000
+172.7%
2,965
+185.6%
0.00%
Q3 2017$22,000
+29.4%
1,038
-8.8%
0.00%
Q2 2017$17,000
-5.6%
1,1380.0%0.00%
Q1 2017$18,000
-33.3%
1,138
-47.5%
0.00%
Q4 2016$27,000
-87.4%
2,168
-71.7%
0.00%
Q3 2016$215,000
-33.8%
7,670
-17.6%
0.00%
Q2 2016$325,000
+32.1%
9,308
+3.6%
0.00%
Q1 2016$246,000
-75.3%
8,982
-69.2%
0.00%
-100.0%
Q4 2015$996,000
+26.4%
29,123
+6.2%
0.00%0.0%
Q3 2015$788,000
-57.7%
27,435
-34.1%
0.00%0.0%
Q2 2015$1,863,000
+55.2%
41,639
+20.0%
0.00%0.0%
Q1 2015$1,200,000
+1263.6%
34,689
+970.6%
0.00%
Q4 2014$88,0003,2400.00%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q4 2017
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 445,200$7,101,0001.80%
Redmile Group, LLC 1,254,342$20,007,0001.30%
Irving Magee Investment Management 166,505$2,656,0001.02%
BROADVIEW ADVISORS LLC 376,050$5,998,0000.83%
Sivik Global Healthcare LLC 101,000$1,611,0000.75%
FRONTIER CAPITAL MANAGEMENT CO LLC 5,455,461$87,015,0000.64%
Iguana Healthcare Management, LLC 75,000$1,196,0000.59%
RIVERBRIDGE PARTNERS LLC 1,464,286$23,355,0000.47%
HERMES INVESTMENT MANAGEMENT LTD 1,772,777$28,276,0000.46%
Endurant Capital Management LP 85,043$1,356,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders